Boron's inclusion on the 2025 U.S. Critical Minerals List reinforces 5E's role as America's next advanced-stage, domestic ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron ...

Boron chemistry, particularly the study of metallacarboranes, has emerged as a dynamic field with significant implications for modern medicinal applications. These compounds, characterised by robust ...

In a vacuum-sealed flask on a lab bench in Germany sits an emerald-green crystal that will cause some jaws to drop. The crystal is the first stable compound containing a triple chemical bond between ...

Epetraborole-treated patients demonstrated clinical improvements in QOL-B and a post-hoc analysis of MACrO 2 with nominal statistical significance when evaluated as continuous measures First drug ...

RESEARCH TRIANGLE PARK – Boron’s value as a plant nutrient is well documented, but it has other properties that make it attractive for crop protection. Products based on the periodic table’s fifth ...

An elite chemical club has a new member, after a team in Germany found a way to link two boron atoms together with a stable triple bond. Boron joins carbon and nitrogen as one of the few elements in ...

"Boron is my element—not that I own boron, but it owns me," Hawthorne reflects after more than a half-century of carrying out boron research. "I think boron is one of the last easy frontiers for the ...

In my case, I happened to be in the right place at the right time, and along with my colleagues, I worked to create the fledgling field of modern boron chemistry. As a result, I managed to make a ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron ...